Autoradiographic localization of 5-HT(1A) receptors in the post-mortem human brain using [3H]WAY-100635

Brain Research

Volumn 745, Issue 1-2, 1997, Pages 96-108

  Hall, H ^a   Lundkvist, C ^a   Halldin, C ^a   Farde, L ^a   Pike, V W ^b   McCarron, J A ^b   Fletcher, A ^c,e   Cliffe, I A ^c,e   Barf, T ^d   Wikstrom H ^d   Sedvall, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c PFIZER INC   (United States)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e Cerebrus Limited   (United Kingdom)

Author keywords

5 HT(1A) receptor; 3H WAY 100635; Hippocampus; Human brain; Whole hemisphere autoradiography

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BUSPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; RADIOLIGAND; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST;

ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; CEREBRAL CORTEX; FEMALE; HUMANS; ISOTOPE LABELING; MALE; MIDDLE AGED; PIPERAZINES; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 17044459906     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01131-6     Document Type: Article

References (48)

1. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram, Naunyn-Schmiedeberg's Arch. Pharmacol., 352 (1995) 157-165.
2. Arvidsson, L.E., Hacksell, U., Nilsson, J.L., Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D. and Wikström, H., 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist, J. Med. Chem., 24 (1981) 921-923.
3. Baldwin, D. and Rudge, S., The role of serotonin in depression and anxiety, Int. Clin. Psychopharmacol., 9 (1995) 41-45.
4. 11C]WAY-100635 in normal and adrenalectomized rats, submitted (1996).
5. Berendsen, H.H., Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol. Ther., 66 (1995) 17-37.
6. Boess, F.G. and Martin, I.L., Review: molecular biology of 5-HT receptors, Neuropharmacology, 33 (1994) 275-317.
7. 2A receptor mRNA in human brain, Brain Res., 676 (1995) 157-168.
8. 1A binding in rat brain. A combined in situ hybridisation/in vitro receptor autoradiographic study, Brain Res., 561 (1991) 51-60.
9. 1A receptor antagonists, Abstract from 206th ACS Meeting, Chicago (1993) 30.
10. 1A receptor antagonist potency and selectivity in a series of 2-aryl-3-(4-arylpiperazin-1-yl)propionamides. Synthesis, pharmacological profile, and molecular modellin, J. Med. Chem., (1996) in press.
11. d'Argy, R., Gillberg, P.-G., Stålnacke, C.-G., Persson, A., Bergström, M., Långström, B., Schoeps, K.O. and Aquilonius, S.-M., In vivo and in vitro receptor autoradiography of the human brain using an C-labelled benzodiazepine analogue, Neurosci. Lett., 85 (1988) 304-310.
12. 1A receptor binding in the human brain post mortem: Effects of age and alcohol, Brain Res., 554 (1991) 56-64.
13. Eison, A.S. and Temple, D.L. Jr., Buspirone: review of its pharmacology and current perspectives on its mechanism of action, Am. J. Med., 80 (1986) 1-9.
14. Farde, L. and Hall, H., Positron emission tomography - examination of chemical transmission in the living human brain. Development of radioligands, Arzneim.-Forsch./Drug Res., 42-41 (1992) 260-264.
15. 1A receptor antagonists: utility as research tools and therapeutic agents, Trends Pharmacol. Sci., 14 (1993) 41-48.
16. 1A receptor antagonist, Behav. Brain Res., 73 (1995) 337-353.
17. 1A receptor antagonist, WAY-100635, Eur. J. Pharmacol., 281 (1995) 81-88.
18. Geary II, W.A. and Wooten, G.F., Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain, J. Pharmacol. Exp. Ther., 225 (1983) 234-240.
19. 3H-PAT, Nature, 305 (1983) 140-142.
20. 1A receptors in rat brain membranes, Eur. J. Pharmacol., 288 (1995) 173-186.
21. 125I]epidepride, Synapse, 23 (1996) 115-123.
22. 3H-raclopride, J. Neural Transm., 73 (1988) 7-21.
23. 2-dopamine receptors, and dopamine and its metabolites in the human brain, Neuropsychopharmacology, 11 (1994) 245-256.
24. 3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain, J. Neurochem., 44 (1985) 1685-1696.
25. Halldin, C., Farde, L., Högberg, T., Hall, H. and Sedvall, G., Carbon-11 Labelling of eticlopride in two different positions - a highly selective high affinity ligand for the study of dopamine D-2 receptor using PET, Appl. Radiat. Isotop., 41 (1990) 669-674.
26. 2 receptor binding in patients with chronic schizophrenia, Psychopharmacology, 112 (1993) S35-S39.
27. Hjorth, S. and Carlsson, A., Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur. J. Pharmacol., 129 (1986) 131-138.
28. Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikström, H., Arvidsson, L.-E., Hacksell, U. and Nilsson, J.L.G., 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and simplified ergot congener with central 5-HT-receptor stimulating activity, J. Neural Transm., 55 (1982) 169-188.
29. 1B recognition sites, Brain Res., 376 (1986) 85-96.
30. 1A receptors in rat brain, Eur. J. Pharmacol., 271 (1994) 515-523.
31. Joyce, J.N., Shane, A., Lexow, N., Winokur, A., Casanova, M.F. and Kleinman, J.E., Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics, Neuropsychopharmacology, 8 (1993) 315-336.
32. 1A receptor antagonist, Brain Res., 673 (1995) 217-225.
33. 1A receptor antagonist, to rat brain, J. Neurochem., 64 (1995) 2716-2726.
34. 3H]WAY-100635 in the mouse, Eur. J. Pharmacol., 271 (1994) 505-514.
35. 1A receptors with positron emission tomography, Life Sci., 55 (1994) PL403-PL407.
36. 1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers, Biochem. Pharmacol., 37 (1988) 3429-3433.
37. 11C]WAY-100635, in monkey and human plasma - A comparison of the behaviour of an identified radioactive metabolite with parent radioligand using PET, Nucl. Med. Biol., 23 (1996) 627-634.
38. Pazos, A., Probst, A. and Palacios, J.M., Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors, Neuroscience, 21 (1987) 97-122.
39. 11C]Ro 15-1788 binding to human brain sections, J. Neurosci. Methods, 36 (1991) 53-61.
40. 11C]WAY 100635, Med. Chem. Res., 5 (1994) 208-227.
41. 11C]WAY-100635, Eur. J. Pharmacol., 283 (1995) R1-R3.
42. 11C]WAY-100635, Eur. J. Pharmacol., 301 (1996) R5-R7.
43. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study, Brain Res., 606 (1993) 273-285.
44. Saxena, P.R., Serotonin receptors: subtypes, functional response and therapeutic relevance, Pharmacol. Ther., 66 (1995) 339-368.
45. Skolnick, P., Paul, S.M. and Weissman, B.A., Preclinical pharmacology of buspirone hydrochloride, Pharmacotherapy, 4 (1984) 308-314.
46. 1A receptors are increased in postmortem prefrontal cortex in schizophrenia, Brain Res., 708 (1996) 209-214.
47. 2 receptor subtype mRNAs in rat brain, J. Comp. Neurol., 351 (1995) 357-373.
48. 1A receptors, J. Clin. Psychopharmacol., 10 (1990) 6S-12S.